Catalyst Wire Dossier Catalyst Wire Dossier

Humira

adalimumab · AbbVie
Drug timelines are a Plus or Pro feature.

234 regulatory and trial events tracked for Humira, covering 2006-06-23 to 2026-08-05. Get the full timeline:

Most recent: EMA Authorised: Humira (adalimumab) — AbbVie Deutschland GmbH & Co. KG

See pricing